Fibroblast growth factors (FGFs) and their receptors (FGFRs) regulate luminal epithelial (LE) cell proliferation in the adult mouse uterus. This study tested the hypothesis that FGFR2 has a biological role in postnatal development and function of the uterus by conditionally deleting Fgfr2 after birth using progesterone receptor (Pgr)-Cre mice. Adult Fgfr2 mutant female mice were initially subfertile and became infertile with increasing parity. No defects in uterine gland development were observed in conditional Fgfr2 mutant mice. In the adult, Fgfr2 mutant mice possessed a histologically normal reproductive tract with the exception of the uterus. The LE of the Fgfr2 mutant uterus was stratified, but no obvious histological differences were observed in the glandular epithelium, stroma, or myometrium. Within the stratified LE, cuboidal basal cells were present and positive for basal cell markers (KRT14 and TRP63). Nulliparous bred Fgfr2 mutants contained normal numbers of blastocysts on Day 3.5 postmating, but the number of embryo implantation sites was substantially reduced on Day 5.5 postmating. These results support the idea that loss of FGFR2 in the uterus after birth alters its development, resulting in LE stratification and peri-implantation pregnancy loss.
INTRODUCTION
Development, growth, and adult function of the uterus and many other epitheliomesenchymal organs are governed by epithelial-stromal interactions that regulate morphogenetically and physiologically important cell behaviors including proliferation, migration, and differentiation [1] [2] [3] . Tissue recombination studies in rodents clearly indicate that uterine mesenchyme/stroma directs and specifies patterns of epithelial development and function, whereas the epithelium is required to support the organization of uterine mesenchyme and myometrial differentiation [1, 2, [4] [5] [6] . In mice, distinct cytodifferentiation of the uterine mesenchyme into endometrial stroma and myometrium is complete by 2 wk after birth. In addition, the glandular epithelium (GE) develops from the luminal epithelium (LE) beginning on Postnatal Day 7 (PD 7), and the uterus is histoarchitecturally mature by 30 days after birth [6] [7] [8] .
Communication between different cell types within epitheliomesenchymal organs is mediated by paracrine, autocrine, and juxtacrine pathways. In the developing neonatal uterus, epithelial-stromal interactions are mediated by Wnt proteins, intrinsic growth factors, and likely changes in the composition and distribution of the extracellular matrix [1, [9] [10] [11] [12] . In the adult uterus, endometrial proliferation and differentiation are regulated by the ovarian steroid hormones, estrogen and progesterone [13] . Under the influence of these steroids, the LE, GE, and stroma express genes important for blastocyst implantation, including cytokines, lipid mediators, enzymes, transporters, and growth factors (for a review, see [14, 15] ). Fibroblast growth factors (FGFs) and their receptors regulate epithelial cell proliferation, migration, and differentiation in many epitheliomesenchymal organs, including the lung, mammary gland, prostate, and kidney [16] [17] [18] [19] [20] . Components of the FGF signaling pathway are expressed in the uterus and may act as paracrine and/or autocrine mediators of epithelialstromal interactions [9, 21] . For example, Fgf7 is expressed in the stroma of the mouse uterus, and treatment of neonatal mice with FGF7 stimulated proliferation of the uterine epithelium [22] . In the adult mouse, progesterone inhibits expression of several Fgfs (Fgf1, Fgf2, Fgf9, Fgf18) in the stroma, which is key for progesterone inhibition of estrogen-stimulated LE cell proliferation in the uterus [9] . The FGFs can bind to extracellular domains of IIIb or IIIc isoforms of FGF receptor (FGFR) 2 as well as FGFR 1, 3, or 4 (for a review, see [23] ). In many organs, FGFR2IIIb is expressed primarily in epithelia and is activated by FGF 1, 3, 7, and 10, which are produced mainly by the mesenchyme; in contrast, FGFR2IIIc is expressed predominantly in the mesenchyme and is activated by FGF 2, 4, 6, 8, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Both FGFR2IIIb and FGFR2IIIc are present in the uterine epithelia but not stroma of PD 15 neonatal mice [21] . In the adult mouse uterus, immunoreactive FGFR2 was detected in both epithelial and stromal compartments of adult mouse uterus [9] .
Collectively, available results support the hypothesis that FGFR2 and its ligands have a biological role in postnatal development and function of the mouse uterus. The definitive role of FGFR2 in postnatal uterine development and function requires a conditional knockout, because global deletion of this gene in the embryo results in embryonic lethality [28] . Therefore, we conditionally ablated Fgfr2 immediately after birth in the uterus using Fgfr2 flox and Pgr Cre mice to test our hypothesis. The conditional ablation of Fgfr2 after birth resulted in progressive stratification of the LE in the uterus and pregnancy loss in the adult. mutation in which exons 7 through 10 were flanked by a single loxP site in intron 6 and an FRT-flanked neo cassette with a 3 0 loxP site in intron 10 [30] . Genotyping was conducted using PCR analysis of DNA extracts from tail biopsies. Briefly, genomic DNA was extracted from the tail biopsies via digestion in 250 ll of 1 M NaOH for 45 min at 958C. Following incubation, 250 ll of 0.05 M Tris-HCl was added to each tube, and samples were vortexed and centrifuged (16 000 3 g) for 3 min. Digested material containing genomic DNA (;3 ll) was combined with primer mix, dNTP MIX (2. 
MATERIALS AND METHODS

Generation of Fgfr2 Conditional Mutant Females
RNA Isolation and Quantitative Real-Time RT-PCR Analysis
Gene expression analysis via quantitative real-time PCR (qPCR) was conducted using methods previously described by our laboratory [31] . Briefly, total RNA was isolated from uterine samples using TRIzol reagent (Invitrogen) according to the manufacturer's recommendations. Genomic DNA was digested with DNase I followed by RNA cleanup using Qiagen RNeasy MinElute (Qiagen). Total RNA (1 lg) was reverse transcribed using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad Laboratories). Control reactions in the absence of reverse transcriptase were prepared for each sample to test for genomic DNA contamination. Real-time PCR analysis was performed using CFX Connect Real-Time PCR Detection System (Bio-Rad) and SsoAdvanced SYBR Green Supermix (Bio-Rad) that uses specific oligonucleotide primers designed by Oligo 7 program (Molecular Biology Insights, Inc.) (see Supplemental Table S1 , available online at www.biolreprod. 
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. Expression of Fgfr2IIIb, Fgfr2IIIc, and Foxa2 mRNA were analyzed using TaqMan Gene Expression Assays (Applied Biosystems). Mouse Rpl13a was used as a reference gene.
Immunohistochemistry
Uteri were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5 lm. Sections were mounted on slides, deparaffinized, and rehydrated in a graded alcohol series. Uterine sections were subjected to antigen retrieval by boiling in 10 mM citrate buffer (pH 6.0) for 10 min, preincubated in 10% normal goat serum in PBS (pH 7.5) for 10 min at room temperature, and then incubated overnight in primary antibody at 48C. The following primary antibodies, diluted in 1% bovine serum albumin in PBS (pH 7.5), were used: anti-FOXA2 at 1.2 lg/ml (LS-C 138006; LifeSpan Biosciences); anti-PTGS2 at 2 lg/ml (160106; Cayman Chemicals); anti-KRT14 at 2 lg/ml (LS-B3916; Lifespan Biosciences); or anti-TRP63 at 1 lg/ ml (4981; Cell Signaling). Negative controls were conducted by substituting the primary antibody with normal rabbit immunoglobulin G (2027; Santa Cruz Biotechnology) at the same final concentration. Sections were washed in PBS and incubated with 5 lg/ml biotinylated secondary antibody (PK-6101; Vector Laboratories) followed by immunoreactive protein visualization using a Vectastain Elite ABC kit (Vector Laboratories) and diaminobenzidine tetrahydrochloride (Sigma-Aldrich) as the chromagen. Sections were counterstained with hematoxylin before affixing the coverslips.
Statistical Analyses
All the quantitative data were subjected to least-squares analyses of variance using the General Linear Models procedures of the Statistical Analysis System (SAS Institute Inc.). In all the analyses, error terms used in tests of significance were identified according to the expectation of the mean squares for error. Significance (P , 0.05) was determined by probability differences of least-squares means. Litter size data were analyzed for effects of genotype (Fgfr2 f/f or Fgfr2 d/d ), parity, and their interaction. For analysis of real-time PCR data from neonatal mice, the Ct values of the target mRNA were analyzed for effects of genotype, day, and their interaction with the Rpl13a or Rn18s used as a covariate. Real-time PCR data are presented as fold change relative to the mRNA level in uteri from control Fgfr2 f/f mice.
RESULTS
Generation of Mice with Conditional Inactivation of Fgfr2 in the Uterus
Global deletion of Fgfr2, which encompasses both isoforms (IIIb and IIIc), results in early embryonic lethality [28] . Null Fgfr2IIIb mice exhibit perinatal lethality, with limb, submaxillary gland, and lung agenesis [17, 32] . In contrast, mice homozygous for the Fgfr2IIIc mutation are viable and fertile, likely due to functional compensation by Fgfr2IIIb [33] . Thus, conditional ablation of both Fgfr2IIIb and Fgfr2IIIc in the uterus was conducted by crossing Pgr Cre mice with Fgfr2
In all the analyses, Pgr þ/þ ;Fgfr2 f/f (also known as Fgfr2 f/f ) female mice were used as the control. The Cre excision activity in the Pgr Cre mouse model is restricted to cells that express the PGR after birth, including the uterus, ovary, oviduct, pituitary gland, and mammary gland [29] . Expression of Pgr is initiated in the reproductive tract only after birth, and PGR is present in the uterine LE by PD 3 and in the stroma by PD 6 [6, 34] .
To assess the efficiency of ablation, expression of Fgfr2IIIb and Fgfr2IIIc was examined in the developing neonatal uterus (Fig. 1) . Expression of both Fgfr2 isoforms was attenuated in the uterus of neonatal Fgfr2 d/d mice (Fig. 1) . Relative levels of Fgfr2IIIb mRNA increased (genotype 3 day, P , 0.01) in the uterus of Fgfr2 f/f but not Fgfr2 d/d mice after birth. Similarly, relative levels of Fgfr2IIIc mRNA increased (day, P , 0.05) in the uterus of Fgfr2 f/f mice after birth, but the levels of Fgfr2IIIc mRNA were lower (genotype, P , 0.01) in mutant mice. Both Fgfr1 and Fgfr3 are also expressed in mouse uterus [9, 21] (Fig. 1) .
f/f mice after birth. In the neonatal and adult uterus, forkhead transcription factor box A2 (FOXA2) is expressed solely in GE and is an essential transcription factor governing endometrial gland differentiation and development in the neonatal mouse uterus [31, [35] [36] [37] . Interestingly, relative levels of Foxa2 mRNA were higher (day 3 genotype, P , 0.05) in the uteri of Fgfr2 d/d than Fgfr2 f/f mice on PD 5 and 12, but not on PD 28 (Fig. 2B) .
Conditional Deletion of Fgfr2 Impairs Female Fertility
To determine the effect of conditional deletion of Fgfr2 on female fertility, Fgfr2 f/f and Fgfr2 d/d mice were bred to wildtype male mice of proven fertility. In a 6-mo breeding trial, Fgfr2 f/f mice exhibited normal fecundity, whereas the Fgfr2
mice displayed severe subfertility ( Table 1 ). The number of pups per litter and litters per female were greater (P , 0.01) in FILANT ET AL. Article 7
females displayed a pronounced parity-dependent decline in fertility (Fig. 3) (Fig. 4, A and B (Fig. 4D) . Next, nulliparous control and mutant mice were mated and analyzed on GD 4.5 (Fig. 4E) 4E) . Prostaglandin endoperoxide synthase two (PTGS2) is expressed in the decidualizing stromal cells at the site of blastocyst attachment and is a marker of appropriate embryo implantation in mice [39] . In both Fgfr2 f/f and Fgfr2 d/d mice, PTGS2 was present in the decidualizing stromal cells adjacent to the implanting blastocyst (Fig. 4E) .
Conditional Deletion of FGFR2 Elicits Epithelial Stratification in the Adult Uterus
As illustrated in Figure 5A , no difference in histoarchitecture of the ovary, oviduct, cervix, or vagina was found in Fgfr2 f/f and Fgfr2 d/d mice. With the exception of the LE, the uterus was not different in control and mutant mice (Fig. 5B) . In contrast to the single layer of columnar LE observed in d/d mice had considerably higher (P , 0.05) levels of keratin 14 (Krt14) mRNA (72-fold increase) and small prolinerich protein 2b (Sprr2b) mRNA (7-fold increase) as compared to control uteri (Fig. 5C ). Both KRT14 and SPRR2B are abundantly expressed in stratified squamous types of epithelia, such as the vagina [40, 41] , but are not normally abundant in the epithelium of the uterus.
To better understand the nature of LE stratification in the Fgfr2 d/d mutant mice, expression of transformation-related protein 63 (TRP63) and KRT14, two basal cell markers [42] , were analyzed in the neonatal and adult uterus (Fig. 6) In the neonatal and adult uterus, FOXA2 is expressed solely in GE and is not present in other cell types [31, [35] [36] [37] .
Immunoreactive FOXA2 was present in the nuclei of GE cells in the neonatal and adult uterus of both Fgfr2 f/f and Fgfr2
mice (Fig. 7A) . Surprisingly, FOXA2-positive cells were clearly present in the stratified LE of the Fgfr2 d/d mutant uterus. In contrast to TRP63 and KRT14, FOXA2 protein was not present in the basal cells and was in the upper layer of cells within the stratified LE, particularly in the adult GD 3.5 uterus. Real-time PCR analysis revealed that the uteri of Fgfr2 d/d mice contained elevated (P , 0.01) levels of Foxa2 mRNA (2-fold increase) as compared to control uteri (Fig. 7B) .
DISCUSSION
The Pgr
Cre mouse was used in this study to conditionally delete Fgfr2 in the female reproductive tract after birth because global Fgfr2 knockout mice are embryonic lethal. This approach resulted in substantial decreases in uterine Fgfr2IIIb mRNA levels on PD 5 and thereafter. Although Fgfr2IIIc mRNA levels were not different in the uterus of control and mutant mice on PD 5, they were lower in mutant mice on PD 12 and 28. The efficiency of deletion in the two Fgfr2 isoforms may be due to differences in cell-specific expression of the different Fgfr2 isoforms as well as Cre activity in the uterus due to Pgr expression. In the neonatal mouse uterus, Pgr expression is initiated in the uterine LE immediately after birth, but PGR protein is not present in the stroma until PD 6 [8] . The FGFR2 and its ligands are implicated in epithelial morphogenesis in numerous organs, including the mammary gland, prostate, lung, and kidney [16] [17] [18] [19] [20] . However, uteri of conditional Fgfr2 deficient mice developed endometrial glands by PD 12 that were histoarchitecturally normal and not different from control mice. These results support the idea that FGFR2 does not have a biological role in endometrial GE differentiation from the LE and subsequent GE development in the neonatal mouse uterus. In contrast, FGFR2 clearly has a biological role in maintaining the identity and integrity of the LE of the uterus.
The development of a stratified LE with basal cells in the postnatal Fgfr2 mutant uterus was an unexpected finding that supports a role for FGFR2 and its ligands in regulating the differentiated phenotype of uterine LE. In the adult mouse, several FGFs act as paracrine mediators of the mitogenic effects of estrogen on the LE of the uterus [9] . A recent study proposed that FGF signaling is involved in vaginal and uterine epithelial differentiation in neonatal mice [21] . Specifically, it was hypothesized that epithelium-derived FGF9 stimulates uterus-type epithelial differentiation through FGFR2IIIc in an autocrine manner. Indeed, FGF9 inhibited the expression of Krt14 whereas the inactivation of FGF9 by a specific antibody induced the expression of Krt14 in the vaginal epithelium, suggesting that the FGF9 inhibits epithelial stratification [21] . Our findings support the hypothesis that FGF9-FGFR2IIIc signaling in the uterine epithelium prevents epithelial stratification because Fgfr2 deficiency triggered stratification in the LE of the uterus. Another possible mechanism for epithelial stratification is mesenchymal-to-epithelial transition. The epithelium of the lower portion of the Müllerian duct expresses TRP63 on Embryonic Day 18, and TRP63-positive cells express KRT14 on PD 2 [8, 43] . The expression of Trp63 is essential for the stratified squamous differentiation because the epithelium of the Müllerian vagina in Trp63 null mice formed a uterus-like layer of columnar epithelium [43] . In the normal uterus, FOXA2 is expressed solely in the GE cells of the uterus [9, 31, 36, 37, 44, 45] and was present in the nuclei of endometrial glands of Fgfr2 d/d mutant mice. Indeed, FOXA2 protein is present in the nuclei of the upper, nonbasal cell layer of the stratified vaginal epithelia in the embryonic, neonatal, and adult mouse (Filant and Spencer, unpublished results). The biological role, if any, of FOXA2 in the vaginal epithelium is not known, but FOXA2 regulates the proliferation of many different cell types [46] [47] [48] . Epithelial stratification is also FILANT ET AL. observed in conditional mutants of Wnt4 (Pgre Cre ;Wnt4 f/f ) [44] . Squamous cell carcinoma accounts for a small portion of endometrial cancers and is thought to arise from the cervix [49] . However, these lesions may arise from the uterus itself based on this study and others [8, 44] . Patients with this type of cancer only survive an average of 40 mo, even after treatment, demonstrating a need to better understand this disease [49] . Therefore, the Fgfr2 conditional mouse model may be useful to understand the origin of uterine squamous cell carcinoma.
The conditional Fgfr2 mutant mice were initially subfertile and then became infertile with increasing parity. The subfertility and infertility do not appear to involve dysfunction of the ovary or oviduct because their histology and function were not different between nulliparous control and Fgfr2 d/d mutant mice. Further, no difference in blastocyst morphology or number was found on GD 3.5. Although unlikely, one possibility is faulty oocyte development (e.g., meiosis) during folliculogenesis may allow for embryo attachment and implantation, but then results in postimplantation embryonic demise. At term, fetal survival was only 37% in first parity uterus, embryo implantation sites were histologically normal with PTGS2 in the decidualizing stromal cells adjacent to the blastocysts attached to the LE. However, implantation was abnormal on GD 5.5 in the Fgfr2 d/d mutant mice based on vascular permeability as detected using intravenous injection of macromolecular blue dye. An increase in vascular permeability and angiogenesis are critical for successful implantation, decidualization, and placentation (for a review, see [50] ). A localized increase in vascular permeability is the first conspicuous sign of blastocyst attachment, and it can be readily visualized by intravenous injection of a macromolecular blue dye [38] . The implantation sites in Fgfr2 d/d mice accumulated observably much less dye than implantation sites in control mice on GD 5.5. An increase in microvascular permeability is thought to facilitate growth and differentiation of the endometrium in preparation for implantation and pregnancy [51] . Vascular endothelial growth factor (VEGF) is proposed as a principal mediator of estrogen-induced increase in uterine vascular permeability [51] . The action of VEGF on endothelial cells is mediated by VEGF receptors FLT1 and KDR (for a review, see [52] ). Interestingly, FGF signaling controls endothelial cell responsiveness to VEGF by modulation of KDR expression [53] , and FGFR2 regulates endothelial cell migration [54] . In the present study, FGF signaling was disrupted via conditional deletion of Fgfr2 in all the PGR-expressing cells, and PGR is expressed by endothelial cells [55] . Thus, these results support the idea that ablation of FGFR2 potentially alters VEGF signaling in endothelial cells, thereby impairing vascular permeability in the uterus. It is tempting to speculate that progressive stratification of the entire LE occurs with increasing parity and contributes to the complete infertility observed in multiparous Fgfr2 mutant mice. The presence of stratified LE together with the impairment in vascular permeability could affect uterine receptivity and stromal decidualization in Fgfr2 d/d uteri. Further studies are necessary to reveal the precise cellular and molecular mechanisms contributing to embryonic loss in conditional Fgfr2 mutant mice.
In summary, conditional ablation of FGFR2 after birth in the mouse uterus resulted in the abnormal appearance of basal cells in the LE, stratification of the LE, and subfertility that progressed to infertility. These findings demonstrate a critical role for FGFR2 in proper postnatal uterine development as well as normal uterine function. Further examination into FGFR2 and its signaling pathways could provide insight into pathways that are deregulated during endometrial diseases, such as endometrial cancer. Accordingly, this mouse model should be useful to determine age-related effects on fertility and basic mechanisms important for uterine receptivity and implantation as well as uterine regeneration and epithelial homeostasis and integrity.
